ANIP
ANI Pharmaceutic (ANIP)
NASDAQ
$73.71-$0.04 (-0.05%)
Price as of Oct 22, 2026 7:30 PM EDT
  • $1.7B
    Market Cap
  • -22.95%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry

Top Holders

Institutional
Mutual Funds
Holder
Ownership %
Shares Held
Change (Shares, %)
Report Date
BLACKROCK, INC.
12.89%
3.0M
+211,154 (+7.14%)
Jun 30, 2026
BLACKROCK FUNDING, INC. /DE
11.93%
2.7M
+48,860 (+1.78%)
Dec 31, 2024
BLACKROCK INC.
11.57%
2.7M
+125,172 (+4.71%)
Jun 30, 2024
VANGUARD GROUP INC
5.68%
1.3M
+27,598 (+2.11%)
Dec 31, 2025
SOLEUS CAPITAL MANAGEMENT, L.P.
3.78%
867,760
+47,517 (+5.48%)
Jun 30, 2026
VANGUARD CAPITAL MANAGEMENT LLC
3.65%
838,224
+15,160 (+1.81%)
Jun 30, 2026
STATE STREET CORP
3.62%
831,647
+60,060 (+7.22%)
Jun 30, 2026

Current Ownership Distribution

  • Institutions295.8M (69.48%)
  • Mutual Funds122.5M (28.78%)
  • Insiders7.4M (1.75%)
  • Other0 (0.00%)

Insider Transactions

  • 1.75% (7.4M)
    Current InsiderOwnership (%, shares)
  • 0
    Number of InsiderBuying (last 12 months)
  • $0.00
    Amount of InsiderBuying (last 12 months)
  • 10
    Number of InsiderSelling (last 12 months)
  • $263.1M
    Amount of InsiderSelling (last 12 months)
Insider Name & Title
Type
Date
Transaction Value
Shares
Share Price
Shares After Transactions
Lalwani Nikhil
PRESIDENT & CEO
Sell
Oct 15, 2026
$388,206.00
5,400
$71.89
333,689
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
Sell
Oct 13, 2026
$36,795.00
500
$73.59
73,424
CAREY STEPHEN P.
SVP & CFO
Sell
Sep 29, 2026
$208,050.00
2,850
$73.00
168,993
Lalwani Nikhil
PRESIDENT & CEO
Sell
Sep 15, 2026
$383,400.00
5,400
$71.00
339,089
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
Sell
Sep 14, 2026
$35,395.00
500
$70.79
73,924
Thoma Jeanne
Sell
Sep 11, 2026
$71,530.00
1,000
$71.53
26,762
CAREY STEPHEN P.
SVP & CFO
Sell
Aug 31, 2026
$207,480.00
2,850
$72.80
171,843
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
Sell
Aug 13, 2026
$37,740.00
500
$75.48
74,424
CAREY STEPHEN P.
SVP & CFO
Sell
Jul 29, 2026
$231,876.00
2,850
$81.36
174,693
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
Sell
Jul 13, 2026
$40,920.00
500
$81.84
77,390
CAREY STEPHEN P.
SVP & CFO
Sell
Jun 29, 2026
$239,742.00
2,850
$84.12
177,543
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
Sell
Jun 12, 2026
$41,015.00
500
$82.03
77,890
HAUGHEY THOMAS
Sell
Jun 08, 2026
$161,760.00
2,000
$80.88
38,878
Thoma Jeanne
Award
May 21, 2026
$0.00
4,357
$0.00
27,762
TANNENBAUM RENEE P
Award
May 21, 2026
$0.00
4,357
$0.00
29,514
HAUGHEY THOMAS
Award
May 21, 2026
$0.00
4,357
$0.00
40,878
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
Sell
Mar 13, 2026
$36,310.00
500
$72.62
79,390
Mutz Christopher
HEAD OF RARE DISEASE
Sell
Mar 13, 2026
$226,525.68
3,162
$71.64
91,309
Rowland Thomas Andrew
SVP, HEAD - ESTABLISHED BRANDS
Sell
Mar 11, 2026
$357,470.52
4,772
$74.91
38,730
Mutz Christopher
HEAD OF RARE DISEASE
Sell
Mar 09, 2026
$267,196.36
3,602
$74.18
94,471
Davis Krista
SVP, CHIEF HR OFFICER
Sell
Mar 09, 2026
$377,099.31
5,087
$74.13
51,946
Mutz Christopher
HEAD OF RARE DISEASE
In Kind
Mar 07, 2026
$245,368.56
3,314
$74.04
98,073
Lalwani Nikhil
PRESIDENT & CEO
In Kind
Mar 07, 2026
$1.3M
17,060
$74.04
404,889
CAREY STEPHEN P.
SVP & CFO
In Kind
Mar 07, 2026
$381,306.00
5,150
$74.04
180,393
Mutz Christopher
HEAD OF RARE DISEASE
Sell
Mar 06, 2026
$157,420.62
2,121
$74.22
101,387
Davis Krista
SVP, CHIEF HR OFFICER
Sell
Mar 06, 2026
$111,375.00
1,485
$75.00
57,033
CAREY STEPHEN P.
SVP & CFO
Exempt
Mar 05, 2026
$163,977.12
3,312
$49.51
9,938
CAREY STEPHEN P.
SVP & CFO
Exempt
Mar 05, 2026
$163,977.12
3,312
$49.51
192,855
CAREY STEPHEN P.
SVP & CFO
Sell
Mar 05, 2026
$249,791.04
3,312
$75.42
189,543
CAREY STEPHEN P.
SVP & CFO
Sell
Mar 05, 2026
$302,240.00
4,000
$75.56
185,543